StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of Calithera Biosciences stock opened at $0.00 on Tuesday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12. The company has a fifty day moving average of $0.02 and a 200 day moving average of $0.02.
Calithera Biosciences Company Profile
Featured Articles
- Five stocks we like better than Calithera Biosciences
- Insider Trading – What You Need to Know
- Survey Reveals: America’s Most Coveted Businesses in 2024
- The 3 Best Blue-Chip Stocks to Buy Now
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- How to Invest in the FAANG Stocks
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.